Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INAVOLISIB vs INDAPAMIDE\PERINDOPRIL ERBUMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

INAVOLISIB vs INDAPAMIDE\PERINDOPRIL ERBUMINE: Safety Overview

Metric INAVOLISIB INDAPAMIDE\PERINDOPRIL ERBUMINE
Total FAERS Reports 188 294
Deaths Reported 6 26
Death Rate 3.2% 8.8%
Hospitalizations 60 210
Average Patient Age 62.1 yrs 67.3 yrs
% Female Patients 99.4% 44.1%
FDA Approval Date Oct 10, 2024 N/A
Manufacturer Genentech, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A